Workflow
华绿生物: 监事会关于2023年限制性股票激励计划首次授予部分第二个归属期归属条件成就和归属名单的核查意见

Core Viewpoint - The supervisory board of Jiangsu Hualv Biological Technology Group Co., Ltd. has verified the conditions and list for the second vesting period of the 2023 restricted stock incentive plan, confirming compliance with relevant laws and regulations [1][2]. Group 1 - The supervisory board ensures that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1]. - The verification process was conducted in accordance with the Company Law, Securities Law, and the Management Measures for Incentive Plans, among other regulations [1]. - The supervisory board has approved the vesting of restricted stock for 35 eligible incentive objects, totaling 1,247,200 shares [2].